Pyrrolopyrazole, potent kinase inhibitors

Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S260100

Reexamination Certificate

active

08067591

ABSTRACT:
Pyrrole pyrazole compounds of formula I, compositions including these compounds and methods of their use are provided. Preferred compounds of formula I have activity as protein kinase inhibitors, including as inhibitors of PAK4.

REFERENCES:
patent: 3423414 (1969-01-01), Blatter
patent: 3526633 (1970-09-01), Gadekar et al.
patent: 3947467 (1976-03-01), Verge et al.
patent: 6013500 (2000-01-01), Minden
patent: 7141568 (2006-11-01), Fancelli et al.
patent: 7531531 (2009-05-01), Fancelli et al.
patent: 7541354 (2009-06-01), Fancelli et al.
patent: 2003/0171357 (2003-09-01), Fancelli et al.
patent: 2007/0004705 (2007-01-01), Brasca et al.
patent: 2009/0221632 (2009-09-01), Fancelli et al.
patent: 48003639 (1973-02-01), None
patent: 51063193 (1976-06-01), None
patent: WO02/12242 (2002-02-01), None
patent: WO2004/013144 (2004-02-01), None
patent: WO2004/056827 (2004-07-01), None
Translation of Opposition paper in connection with Ecuador Application No. SP-07-7580, Date considered in Apr. 11, 2008.
Opposition paper in connection with Costa Rican Application No. 9238 (English Translation Provided), Apr. 11, 2008.
Bagrodia, S., et al., “Cdc42 and PAK-Mediated signaling Leads to Jun Kinase and p38 Mitogen-Activated Protein Kinase Activation,”The Journal of Biological Chemistry, 1995, 27995-24998, vol. 270, No. 2.
Brown, J., et al., “Human Ste20 Homologue hPAK1 Links GTPases to the JNK MAP Kinase Pathway,”Current Biology, 1996, 598-605, vol. 6, No. 5.
Daniels, R., et al., “p21-Activated Protein Kinase : A Crucial Component of Morphological Signaling ?in ,”Trends Biochemical Science, 1999, 350-355, vol. 24.
Gnesutta, N., et al., “The serine/Threonine Kinase PAK4Prevents Caspase Activation and Protects Cells From Apoptosis,”The Journal of Biological Chemistry, 2001, 14414-14419, vol. 276, No. 17.
King, A., et al., “The Protein Kinase Pak3 Positively Regulates Raf-1 Activity Through Phosphorylation of Serine 338,”Nature, 1998, 180-183, vol. 396.
Manser, E., et al., “A brain Serine/Threonine Protein Kinase Activated by Cdc42 and Rac1,”Nature, 1994, 40-46, viol. 367.
Qu, J., et al., “Activated PAK4 Regulates Cell Adhesion and Anchorage-Independent Growth,” Molecular and Cellular Biology, 2001, 3523-3533, vol. 21, No. 10.
Roig, J., et al., “p21-Activated Protein Kinase γ-PAK Is Activated by Ionizing Radiation and Other DNA-Damaging Agents,”The Journal of Biological Chemistry, 1999, 31119-31122, vol. 274, No. 44.
Rudel, T., et al., “Membrane and Morphological Changes in Apoptotic Cells Regulated by Caspase-Mediated activation of PAK2,”Science, 1997, 1571-1574, vol. 276.
Schurmann, A., et al., “p21-Activiated Kinase 1 Phosphorylates The Death Agonist Bad and Protects Cells From Apoptosis,”Molecular and Cellular Biology, 2000, 453-461, vol. 20.
Sells, M., et al., “Emerging From the Pak : The p21-Activated Protein Kinase Family,”Trends in Cell Biology, 1997, 162-167, vol. 7.
Sun, H., et al., “Regulation of the Protein Kinase Raf-1 Oncogenic Ras Through Phosphatidylinositol 3-Kinase, Cdc42/Rac and Pak,” Current Biology, 2000, 281-284, vol. 10.
Yablonski, D., et al., “A Nck-Pak1 Signaling Module Is Required for T-Cell Receptor-Mediated Activation of NFAT, But Not of JNK,” EMBO Journal, 1998, 5647-5657, vol. 17, No. 19.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrrolopyrazole, potent kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolopyrazole, potent kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolopyrazole, potent kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4274049

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.